Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignanciesHolly K. Koblish, Peggy Scherle|PLoS ONE|2018Cited by 53
A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted ActivityJonathan Rios‐Doria, Holly K. Koblish|Frontiers in Oncology|2020Cited by 42